We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.



High Throughput Gene to Antibody Production to screen MORE

High Throughput Gene to Antibody Production to screen MORE

High throughput (HTP) gene to antibody production provides the most cost effective option for small-scale recombinant antibodies. This popular service combines GenScript's expertise in high-throughput gene synthesis with a proprietary transient antibody expression technology to produce high quality recombinant antibodies for both therapeutic antibody drug candidates and reagent antibodies.

Examples of antibody sequences accepted: variable region sequenced from hybridoma, hits (Fab or scFv) selected from display library based method, sequences from single B cell and/or repertoire analysis via next generation sequencing (NGS), and many more.

You provide us the sequences of the fragments and we take care of the rest. Deliverables can be supernatant or purified antibodies. There is no additional set-up fee, and the cost of gene synthesis is waived.

Fast Delivery: 13-18 BD from gene synthesis to delivery (standard package)

Flexible Options: Fabs, scFv, VHH, or other fragments fused with Fc

Cost Effective: One-stop solution with an Economy option available

About GenScript
GenScript Biotech Corporation (GenScript) is a world leading technology and service provider of life science research and development and manufacture. Built upon its solid gene synthesis technology, GenScript is divided into four major platforms including the life science service and product platform, the biologics contract development and manufacturing organization platform, the industrial synthetic products platform and the integrated global cell therapy platform. Driven by the corporate mission of “make people and nature healthier through biotechnology”, GenScript strives to become the most trustworthy biotech company in the world.
Interested in seeing more content from GenScript?
Discover all their latest news, webinars, products and more by clicking the link below.